Newtyn Management’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-140,000
| Closed | -$816K | – | 33 |
|
2024
Q4 | $816K | Hold |
140,000
| – | – | 0.14% | 32 |
|
2024
Q3 | $1.67M | Hold |
140,000
| – | – | 0.26% | 35 |
|
2024
Q2 | $1.51M | Sell |
140,000
-10,000
| -7% | -$108K | 0.28% | 33 |
|
2024
Q1 | $1.7M | Hold |
150,000
| – | – | 0.34% | 32 |
|
2023
Q4 | $2.1M | Hold |
150,000
| – | – | 0.41% | 32 |
|
2023
Q3 | $1.85M | Sell |
150,000
-25,000
| -14% | -$309K | 0.46% | 32 |
|
2023
Q2 | $1.58M | Sell |
175,000
-200,000
| -53% | -$1.81M | 0.37% | 34 |
|
2023
Q1 | $1.3M | Buy |
375,000
+15,000
| +4% | +$52.1K | 0.26% | 54 |
|
2022
Q4 | $882K | Sell |
360,000
-40,000
| -10% | -$98K | 0.18% | 56 |
|
2022
Q3 | $1.1M | Sell |
400,000
-100,000
| -20% | -$276K | 0.24% | 49 |
|
2022
Q2 | $2.04M | Buy |
+500,000
| New | +$2.04M | 0.39% | 40 |
|